349 related articles for article (PubMed ID: 31990272)
1. Preclinical murine tumor models: a structural and functional perspective.
Guerin MV; Finisguerra V; Van den Eynde BJ; Bercovici N; Trautmann A
Elife; 2020 Jan; 9():. PubMed ID: 31990272
[TBL] [Abstract][Full Text] [Related]
2. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
3. Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo.
Waldmeier L; Meyer-Schaller N; Diepenbruck M; Christofori G
PLoS One; 2012; 7(11):e48651. PubMed ID: 23144919
[TBL] [Abstract][Full Text] [Related]
4. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.
Bandyopadhyay A; Wang L; Agyin J; Tang Y; Lin S; Yeh IT; De K; Sun LZ
PLoS One; 2010 Apr; 5(4):e10365. PubMed ID: 20442777
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
Ding W; You H; Dang H; LeBlanc F; Galicia V; Lu SC; Stiles B; Rountree CB
Hepatology; 2010 Sep; 52(3):945-53. PubMed ID: 20564331
[TBL] [Abstract][Full Text] [Related]
7. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.
Dunlap SM; Chiao LJ; Nogueira L; Usary J; Perou CM; Varticovski L; Hursting SD
Cancer Prev Res (Phila); 2012 Jul; 5(7):930-42. PubMed ID: 22588949
[TBL] [Abstract][Full Text] [Related]
8. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
Jung HY; Fattet L; Yang J
Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
[TBL] [Abstract][Full Text] [Related]
11. The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.
Fedele M; Sgarra R; Battista S; Cerchia L; Manfioletti G
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054987
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of advanced spontaneous metastasis for experimental therapeutics.
Francia G; Cruz-Munoz W; Man S; Xu P; Kerbel RS
Nat Rev Cancer; 2011 Feb; 11(2):135-41. PubMed ID: 21258397
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition in tumor metastasis.
Yeung KT; Yang J
Mol Oncol; 2017 Jan; 11(1):28-39. PubMed ID: 28085222
[TBL] [Abstract][Full Text] [Related]
14. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
Chou MY; Yang MH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
[TBL] [Abstract][Full Text] [Related]
15. A COMPARISON OF SURVIVAL TIME AND EXTENT OF TUMOR METASTASES IN MICE WITH TRANSPLANTED, INDUCED AND SPONTANEOUS TUMORS.
WEXLER H; MINTON JP; KETCHAM AS
Cancer; 1965 Aug; 18():985-94. PubMed ID: 14326497
[No Abstract] [Full Text] [Related]
16. EMT, MET, Plasticity, and Tumor Metastasis.
Bakir B; Chiarella AM; Pitarresi JR; Rustgi AK
Trends Cell Biol; 2020 Oct; 30(10):764-776. PubMed ID: 32800658
[TBL] [Abstract][Full Text] [Related]
17. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
Pietilä M; Ivaska J; Mani SA
Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
[TBL] [Abstract][Full Text] [Related]
18. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
Paez-Ribes M; Man S; Xu P; Kerbel RS
PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
[TBL] [Abstract][Full Text] [Related]
19. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
20. TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy.
Yang L
Curr Mol Med; 2010 Jun; 10(4):374-80. PubMed ID: 20455854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
